These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 26751262)

  • 1. A novel treatment adjunct for aspirin exacerbated respiratory disease: the low-salicylate diet: a multicenter randomized control crossover trial.
    Sommer DD; Rotenberg BW; Sowerby LJ; Lee JM; Janjua A; Witterick IJ; Monteiro E; Gupta MK; Au M; Nayan S
    Int Forum Allergy Rhinol; 2016 Apr; 6(4):385-91. PubMed ID: 26751262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of aspirin exacerbated respiratory disease with a low salicylate diet: a pilot crossover study.
    Sommer DD; Hoffbauer S; Au M; Sowerby LJ; Gupta MK; Nayan S
    Otolaryngol Head Neck Surg; 2015 Jan; 152(1):42-7. PubMed ID: 25344589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of low salicylate diet on clinical and inflammatory markers in patients with aspirin exacerbated respiratory disease - a randomized crossover trial.
    Sowerby LJ; Patel KB; Schmerk C; Rotenberg BW; Rocha T; Sommer DD
    J Otolaryngol Head Neck Surg; 2021 Apr; 50(1):27. PubMed ID: 33892819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: A prospective cohort study.
    Cooper T; Greig SR; Zhang H; Seemann R; Wright ED; Vliagoftis H; Côté DWJ
    Auris Nasus Larynx; 2019 Aug; 46(4):526-532. PubMed ID: 30577986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin-exacerbated respiratory disease and current treatment modalities.
    Sakalar EG; Muluk NB; Kar M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease.
    Cho KS; Soudry E; Psaltis AJ; Nadeau KC; McGhee SA; Nayak JV; Hwang PH
    Otolaryngol Head Neck Surg; 2014 Oct; 151(4):575-81. PubMed ID: 25118195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease.
    Berges-Gimeno MP; Simon RA; Stevenson DD
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):474-8. PubMed ID: 12452205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.
    Walters KM; Waldram JD; Woessner KM; White AA
    Am J Rhinol Allergy; 2018 Jul; 32(4):280-286. PubMed ID: 29682983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin sensitivity does not compromise quality-of-life outcomes in patients with Samter's triad.
    Jang DW; Comer BT; Lachanas VA; Kountakis SE
    Laryngoscope; 2014 Jan; 124(1):34-7. PubMed ID: 23712910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease.
    Pezato R; Świerczyńska-Krępa M; Niżankowska-Mogilnicka E; Holtappels G; De Ruyck N; Sanak M; Derycke L; Van Crombruggen K; Bachert C; Pérez-Novo CA
    Cytokine; 2016 Jan; 77():157-67. PubMed ID: 26615369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey.
    Bavbek S; Yilmaz I; Celik G; Aydin O; Erkekol FÖ; Orman A; Kurt E; Ediger D; Dursun B; Abadoğlu O; Ozşeker F; Akkaya E; Karakiş GP; Canbakan S; Yüksel S; Misirligil Z
    Allergol Immunopathol (Madr); 2012; 40(4):225-30. PubMed ID: 21889254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin-Exacerbated Respiratory Disease.
    Walgama ES; Hwang PH
    Otolaryngol Clin North Am; 2017 Feb; 50(1):83-94. PubMed ID: 27888917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin exacerbated respiratory disease: Current topics and trends.
    Rodríguez-Jiménez JC; Moreno-Paz FJ; Terán LM; Guaní-Guerra E
    Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical outcomes in aspirin-exacerbated respiratory disease without aspirin desensitization.
    Grose E; Lee DJ; Yip J; Cottrell J; Sykes J; Lee JK; Lee JM
    Int Forum Allergy Rhinol; 2020 Oct; 10(10):1149-1157. PubMed ID: 32558318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin-Exacerbated Respiratory Disease and the Unified Airway: A Contemporary Review.
    Walters BK; Hagan JB; Divekar RD; Willson TJ; Stokken JK; Pinheiro-Neto CD; O'Brien EK; Choby G
    Otolaryngol Clin North Am; 2023 Feb; 56(1):107-124. PubMed ID: 36283868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of modified endoscopic Lothrop in aspirin-exacerbated respiratory disease with nasal polyposis.
    Morrissey DK; Bassiouni A; Psaltis AJ; Naidoo Y; Wormald PJ
    Int Forum Allergy Rhinol; 2016 Aug; 6(8):820-5. PubMed ID: 26992029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes after complete endoscopic sinus surgery and aspirin desensitization in aspirin-exacerbated respiratory disease.
    Adappa ND; Ranasinghe VJ; Trope M; Brooks SG; Glicksman JT; Parasher AK; Palmer JN; Bosso JV
    Int Forum Allergy Rhinol; 2018 Jan; 8(1):49-53. PubMed ID: 29105347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current complications and treatment of aspirin-exacerbated respiratory disease.
    Cook KA; Stevenson DD
    Expert Rev Respir Med; 2016 Dec; 10(12):1305-1316. PubMed ID: 27817219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary Fatty Acid Modification for the Treatment of Aspirin-Exacerbated Respiratory Disease: A Prospective Pilot Trial.
    Schneider TR; Johns CB; Palumbo ML; Murphy KC; Cahill KN; Laidlaw TM
    J Allergy Clin Immunol Pract; 2018; 6(3):825-831. PubMed ID: 29133219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history and clinical features of aspirin-exacerbated respiratory disease.
    Fahrenholz JM
    Clin Rev Allergy Immunol; 2003 Apr; 24(2):113-24. PubMed ID: 12668892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.